An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...
Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD. He adds that AI supports drug repurposing by uncovering new actionable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback